Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vermeire

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
Genes and Immunity|May 7, 2010
Evidence that glioma-associated oncogene homolog 1 is not a universal risk gene for inflammatory bowel disease in CaucasiansR W Bentley, I Cleynen, R B Gearry, et al.
Gut|January 14, 2005
Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's diseaseM Pierik, G De Hertogh, S Vermeire, et al.
Veterinary Journal (London, England : 1997)|March 30, 2010
Recognition of anatomical predilection sites in canine elbow pathology on bone scans using micro-single photon emission tomographyK Peremans, S Vermeire, A Dobbeleir, et al.
Alimentary Pharmacology & Therapeutics|July 14, 2005
The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximabP Persoons, S Vermeire, K Demyttenaere, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2017
Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical responseE Dreesen, T Van Stappen, V Ballet, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2012
Letter: detection of infliximab levels and anti-infliximab antibodies--comparison of three different assays; authors' replyD J Buurman, N Vande Casteele, M G G Sturkenboom, et al.
Gut|June 15, 2004
Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitisD Franchimont, S Vermeire, H El Housni, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2012
Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assaysN Vande Casteele, D J Buurman, M G G Sturkenboom, et al.
The Journal of Pathology|June 2, 2006
Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversityG De Hertogh, J Aerssens, R de Hoogt, et al.
Alimentary Pharmacology & Therapeutics|March 27, 2004
The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort studyL Marchal, G D'Haens, G Van Assche, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Genes and Immunity|May 7, 2010
Evidence that glioma-associated oncogene homolog 1 is not a universal risk gene for inflammatory bowel disease in CaucasiansR W Bentley, I Cleynen, R B Gearry, et al.
Gut|January 14, 2005
Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's diseaseM Pierik, G De Hertogh, S Vermeire, et al.
Veterinary Journal (London, England : 1997)|March 30, 2010
Recognition of anatomical predilection sites in canine elbow pathology on bone scans using micro-single photon emission tomographyK Peremans, S Vermeire, A Dobbeleir, et al.
Alimentary Pharmacology & Therapeutics|July 14, 2005
The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximabP Persoons, S Vermeire, K Demyttenaere, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2017
Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical responseE Dreesen, T Van Stappen, V Ballet, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2012
Letter: detection of infliximab levels and anti-infliximab antibodies--comparison of three different assays; authors' replyD J Buurman, N Vande Casteele, M G G Sturkenboom, et al.
Gut|June 15, 2004
Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitisD Franchimont, S Vermeire, H El Housni, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2012
Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assaysN Vande Casteele, D J Buurman, M G G Sturkenboom, et al.
The Journal of Pathology|June 2, 2006
Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversityG De Hertogh, J Aerssens, R de Hoogt, et al.
Alimentary Pharmacology & Therapeutics|March 27, 2004
The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort studyL Marchal, G D'Haens, G Van Assche, et al.
Pageof 14